Regenerative Medicine · Drug Discovery
REPROCELL news and milestones
REPROCELL: 8 headlines on record, 1 headline in the last 90 days.
Data updated Nov 18, 2026 · Back to the company report
8Headlines
1In 90 days
0Milestones
Headlines
Sep 252026
News · investing.com
Aug 202026
News · uk.investing.com
Jun 242026
News · YahooFinance
REPROCELL Inc. today announced the submission of an application for manufacturing and marketing approval in Japan for the regenerative medicine product Stemchymal, for which the…
Jun 92026
Mar 32026
Press release · morningstar.com
Jan 282026
Press release · PRNewswire
/PRNewswire/ -- REPROCELL today announced the commercial launch of StemEdit, its clinical gene editing services and new gene-edited iPSC product lines...
Oct 22, 20252025
News · YahooFinance
REPROCELL is a leader in producing clinically relevant human induced pluripotent stem cells (hiPSCs). These hiPSCs are generated from healthy donors that have been ethically cons…
News · reuters.com
Sources: the outlets named on each headline, each story once
How to cite
REPROCELL, News. Alion, Nov 18, 2026. https://alion.io/company/reprocell/news
